Renaissance Technologies Stocks Performance Guide: Neurocrine Biosciences Inc (NBIX)
NBIX has no dividends.
Table and Chart of NBIX Performance
See what a $1,000 investment in NBIX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NBIX Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $13.89 |
| End Date | May-16-2024 |
| End Price | $141.91 |
| # Prices | 121 |
| Min Date | Jul-31-2014 |
| Min Price | $13.58 |
| Max Date | May-16-2024 |
| Max Price | $141.91 |
| Total Return | 921.67% |
| Annualized Return | 25.92% |
| Current Value of $1,000 Purchase | $10,217 |
| Number Returns | 7,260 |
| Average Return | 103.67% |
| Number Profitable Returns | 6,074 |
| Percent Profitable Returns | 83.66% |
| Number Unprofitable Returns | 1,186 |
| Percent Unprofitable Returns | 16.34% |
| Profitable to Unprofitable Returns Ratio | 5.12 |
| NBIX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $14,290,454,000 |
| Beta | 0.279 | Price to Sales | 7.18 |
| Earnings per Share | $3.6800 |
| PE Ratio | 38.59 |
| PE to Growth Ratio | 0.442 |
| Price to Book | 6.07 |
| PRICE DATA | |
| 52 Week High | $148.37 |
| 52 Week Low | $89.04 |
| Analyst Target Price | $158.6 |
| 50-Day Moving Average | $138.25 |
| 200-Day Moving Average | $124.04 |
| FINANCIAL DATA | |
| Revenue per Share | $20.15 |
| Revenue | $1,982,000,000 |
| Profit Margin | 18.6% |
| Return on Equity | 18.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NBIX Compare Returns with S&P 500
NBIX Trendline Chart
NBIX Moving Average Chart
NBIX Stock Return Map - See Patterns of Gains and Losses
NBIX Stock Returns/Purchase Dates